Find your path to Ian
75 people in our graph share verified history with Ian — schools, employers, funds. One of them is your warm intro.
Aydin SenkutunlockedIan: together at Boston University (1990–1992)
×11Ian: together at Advent Life Sciences
About
Ian J. Nicholson joined Advent in 2012 after an international career in life sciences. He currently serves as Chief Business Officer of Eloxx Pharmaceuticals and previously was CEO of F2G Limited, an antifungal company; earlier roles included Senior Vice President of Business Development at Celltech Group plc and senior commercial positions at Chroma Therapeutics, Oxford Asymmetry International, Lonza AG and Amersham International. He holds a B.Sc. (Hons.) from University College London and an MBA from Boston University.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- LifeArcMember of the Board of Trusteescurrent2021 — presentGreater London, England, United Kingdom
- Advent Life Sciences LLPOperating Partnercurrent2012 — presentLondon Area, United Kingdom
- Bioventix plcChairmancurrent2004 — presentFarnham, Surrey
- Bioventix plcChairman of the Boardcurrent2004 — present
- Clinigen GroupNon Executive Director2012 — 2021Burton-on-Trent, UK
- F2G LimitedChief Executive Officer2013 — 2021Manchester Area, United Kingdom
- Consort Medical plcNon Executive Director2012 — 2020Hemel Hempstead, England, United Kingdom
Skills & more
Biotechnology14Lifesciences13Venture Capital11Pharmaceutical Industry11Drug Discovery11Medical Devices3CRO2Drug Development12Mergers & Acquisitions4Technology Transfer4
From Ian's professional profile.
Investments
Board seats
Bioventix plc
Per the firm's website.
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dale Pfost
Executive Officer at Advent Life Sciences
Dominic Schmidt
General Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Frequently asked questions
- Who is Ian J. Nicholson?
- Ian J. Nicholson joined Advent in 2012 after an international career in life sciences. He currently serves as Chief Business Officer of Eloxx Pharmaceuticals and previously was CEO of F2G Limited, an antifungal company; earlier roles included Senior Vice President of Business Development at Celltech Group plc and senior commercial positions at Chroma Therapeutics, Oxford Asymmetry International, Lonza AG and Amersham International. He holds a B.Sc. (Hons.) from University College London and an MBA from Boston University.
- Where does Ian J. Nicholson work?
- Ian J. Nicholson is Operating Partner at Advent Life Sciences.
- What does Ian J. Nicholson invest in?
- Ian J. Nicholson invests in Biotech.
- What boards does Ian J. Nicholson sit on?
- Ian J. Nicholson holds tracked board seats at Bioventix plc.
- Where did Ian J. Nicholson go to school?
- Ian J. Nicholson studied at Boston University (Executive MBA Programme, Executive MBA); UCL (B.Sc. Physiology).
